Cytokinetics, Incorporated logo
Cytokinetics, Incorporated CYTK
$ 56.36 1.55%

Quarterly report 2024-Q2
added 08-09-2024

report update icon

Cytokinetics, Incorporated Balance Sheet 2011-2024 | CYTK

Annual Balance Sheet Cytokinetics, Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-36.7 M 11.1 M -50.4 M 55.5 M 282 M 157 K 50.3 M -37 M -4.07 M -20.2 M -20.2 M -14.9 M -18.7 M

Long Term Debt

58.4 M 63.8 M 47.4 M 136 M 129 M 39.8 M 31.8 M 27.4 M 14.6 M - - - -

Long Term Debt Current

17.9 M 12.8 M 14.9 M 2.78 M 4.62 M 2.61 M - 2.5 M - - - - -

Total Non Current Liabilities

- - - - 275 M 163 M 153 M 42.5 M 15 M 17 M 2.04 M 361 K 3 K

Total Current Liabilities

103 M 84.6 M 71.9 M 31.2 M 26 M 22.2 M 32.4 M 33.3 M 31.6 M 23.9 M 26.7 M 7.1 M 4.59 M

Total Liabilities

1.21 B 1.12 B 597 M 420 M 301 M 185 M 185 M 75.8 M 46.6 M 40.9 M 28.7 M 7.47 M 4.6 M

Deferred Revenue

- - - - - - 9.57 M 8.06 M 20.9 M 17 M 14.7 M 76 K -

Retained Earnings

-2.11 B -1.59 B -1.21 B -992 M -865 M -743 M -646 M -518 M -535 M -497 M -483 M -449 M -409 M

Total Assets

824 M 1.01 B 841 M 534 M 290 M 211 M 295 M 170 M 115 M 133 M 83.2 M 77.6 M 52.8 M

Cash and Cash Equivalents

113 M 65.6 M 113 M 83 M 36.4 M 42.3 M 125 M 66.9 M 65.1 M 20.2 M 20.2 M 14.9 M 18.8 M

Book Value

-386 M -108 M 244 M 113 M -10.9 M 25.9 M 110 M 94.4 M 68.6 M 92.1 M 54.4 M 70.1 M 48.2 M

Total Shareholders Equity

-386 M -108 M 244 M 113 M -10.9 M 25.9 M 110 M 94.4 M 68.6 M 92.1 M 54.4 M 70.1 M 48.2 M

All numbers in USD currency

Quarterly Balance Sheet Cytokinetics, Incorporated

2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

92.8 M 60.9 M 62.5 M 64.1 M 63.8 M 63.5 M - 61.2 M 47.4 M 30.2 M 35.5 M 40.9 M 46.2 M 46.2 M 46.2 M 46.2 M 45.1 M 45.1 M 45.1 M 45.1 M 39.8 M 39.8 M 39.8 M 39.8 M 31.8 M 31.8 M 31.8 M 31.8 M 27.4 M 27.4 M 27.4 M 27.4 M 14.6 M 14.6 M 14.6 M 14.6 M - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

1.42 B 1.18 B 1.11 B 1.12 B 1.12 B 1.09 B - 740 M 597 M 579 M 548 M 509 M 420 M 420 M 420 M 420 M 301 M 301 M 301 M 301 M 185 M 185 M 185 M 185 M 185 M 185 M 185 M 185 M 75.8 M 75.8 M 75.8 M 75.8 M 46.6 M 46.6 M 46.6 M 46.6 M 40.9 M 40.9 M 40.9 M 40.9 M 28.7 M 28.7 M 28.7 M 28.7 M 7.47 M 7.47 M 7.47 M 7.47 M 4.6 M 4.6 M 4.6 M 4.6 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - 4.51 M 9.57 M 9.57 M 9.57 M 9.57 M 8.06 M 8.06 M 8.06 M 8.06 M 20.9 M 20.9 M 20.9 M 20.9 M 17 M 17 M 17 M 17 M 14.7 M 14.7 M 14.7 M 14.7 M 76 K 129 K - - - - 263 K -

Retained Earnings

-2.39 B -1.98 B -1.85 B -1.72 B -1.59 B -1.45 B - -1.29 B -1.21 B -1.18 B -1.1 B -1.04 B -992 M -992 M -992 M -992 M -865 M -865 M -865 M -865 M -743 M -743 M -743 M -743 M -646 M -646 M -646 M -646 M -518 M -518 M -518 M -518 M -535 M -535 M -535 M -535 M -497 M -497 M -497 M -497 M -483 M -483 M -483 M -483 M -449 M -449 M -449 M -449 M -409 M -409 M -409 M -409 M

Total Assets

1.52 B 741 M 780 M 890 M 1.01 B 1.08 B - 856 M 841 M 828 M 564 M 577 M 534 M 534 M 534 M 534 M 290 M 290 M 290 M 290 M 211 M 211 M 211 M 211 M 295 M 295 M 295 M 295 M 170 M 170 M 170 M 170 M 115 M 115 M 115 M 115 M 133 M 133 M 133 M 133 M 83.2 M 83.2 M 83.2 M 83.2 M 77.6 M 77.6 M 77.6 M 77.6 M 52.8 M 52.8 M 52.8 M 52.8 M

Cash and Cash Equivalents

190 M 99.7 M 68.6 M 102 M 65.6 M 106 M - 115 M 113 M 90.6 M 37.2 M 44.6 M 83 M 83 M 83 M 83 M 36.4 M 36.4 M 36.4 M 36.4 M 42.3 M 42.3 M 42.3 M 42.3 M 125 M 125 M 125 M 125 M 66.9 M 66.9 M 66.9 M 66.9 M 65.1 M 65.1 M 65.1 M 65.1 M 20.2 M 20.2 M 20.2 M 20.2 M 20.2 M 20.2 M 20.2 M 20.2 M 14.9 M 14.9 M 14.9 M 14.9 M 18.8 M 18.8 M 18.8 M 18.8 M

Book Value

109 M -439 M -333 M -229 M -108 M -16 M - 116 M 244 M 249 M 16.5 M 67.8 M 113 M 113 M 113 M 113 M -10.9 M -10.9 M -10.9 M -10.9 M 25.9 M 25.9 M 25.9 M 25.9 M 110 M 110 M 110 M 110 M 94.4 M 94.4 M 94.4 M 94.4 M 68.6 M 68.6 M 68.6 M 68.6 M 92.1 M 92.1 M 92.1 M 92.1 M 54.4 M 54.4 M 54.4 M 54.4 M 70.1 M 70.1 M 70.1 M 70.1 M 48.2 M 48.2 M 48.2 M 48.2 M

Total Shareholders Equity

109 M -439 M -333 M -229 M -108 M -16 M 111 M 116 M 244 M 249 M 16.5 M 67.8 M 113 M 113 M 113 M 113 M -10.9 M -10.9 M -10.9 M -10.9 M 25.9 M 25.9 M 25.9 M 25.9 M 110 M 110 M 110 M 110 M 94.4 M 94.4 M 94.4 M 94.4 M 68.6 M 68.6 M 68.6 M 68.6 M 92.1 M 92.1 M 92.1 M 92.1 M 54.4 M 54.4 M 54.4 M 54.4 M 70.1 M 70.1 M 70.1 M 70.1 M 48.2 M 48.2 M 48.2 M 48.2 M

All numbers in USD currency